Lineage Cell Therapeutics, Inc. Quarterly Goodwill in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Lineage Cell Therapeutics, Inc. quarterly Goodwill history and growth rate from Q1 2019 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $10.7M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10.7M $0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $10.7M $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.7M $0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.7M $0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $10.7M $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $10.7M $0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $10.7M $0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $10.7M $0 0% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $10.7M $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $10.7M $0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $10.7M $0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $10.7M $0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $10.7M $0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $10.7M $0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $10.7M $0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $10.7M $0 0% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $10.7M -$2.31M -17.8% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $10.7M -$2.31M -17.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $10.7M -$2.31M -17.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $10.7M Dec 31, 2019 10-K 2021-03-11
Q3 2019 $13M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $13M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $13M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.